Immix Biopharma (IMMX) Research & Development (2021 - 2026)
Quarterly results put Research & Development at $6.0 million for Q1 2026, up 202.8% from a year ago — trailing twelve months through Mar 2026 was $20.3 million (up 102.25% YoY), and the annual figure for FY2025 was $16.3 million, up 43.97%.
Immix Biopharma has reported Research & Development over the past 6 years, most recently at $6.0 million for Q1 2026.
- Research & Development reached $6.0 million in Q1 2026 per IMMX's latest filing, up from $5.7 million in the prior quarter.
- Across five years, Research & Development topped out at $6.0 million in Q1 2026 and bottomed at $607751.0 in Q2 2022.
- Median Research & Development over the past 5 years was $2.2 million (2024), compared with a mean of $2.7 million.
- The largest annual shift saw Research & Development surged 24397.17% in 2022 before it plummeted 55.68% in 2024.
- Over 5 years, Research & Development stood at $2.3 million in 2022, then surged by 37.05% to $3.1 million in 2023, then tumbled by 55.68% to $1.4 million in 2024, then skyrocketed by 316.7% to $5.7 million in 2025, then increased by 4.43% to $6.0 million in 2026.
- Business Quant data shows Research & Development for IMMX at $6.0 million in Q1 2026, $5.7 million in Q4 2025, and $4.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.54 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -2.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | 5.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.98 Mn |
| Dec 31, 2025 | 5.73 Mn |
| Sep 30, 2025 | 4.58 Mn |
| Jun 30, 2025 | 3.97 Mn |
| Mar 31, 2025 | 1.98 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | 2.22 Mn |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | 2.11 Mn |
| Jun 30, 2023 | 2.21 Mn |
| Mar 31, 2023 | 1.32 Mn |
| Dec 31, 2022 | 2.26 Mn |
| Sep 30, 2022 | 695,937.00 |
| Jun 30, 2022 | 607,751.00 |
| Mar 31, 2022 | 629,531.00 |
| Dec 31, 2021 | 9,236.00 |
| Sep 30, 2021 | 29,690.00 |
| Jun 30, 2021 | 62,761.00 |
| Mar 31, 2021 | 24,840.00 |